Biosolids Market Size, Share and Growth Outlook, 2026

Biosolids Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Biosolids Market size is forecast to increase from $1.98 Billion in 2026 to $2.77 Billion in 2034 at a CAGR of 4.3% between 2026 and 2034.

The Biosolids market report provides detailed analysis and outlook of Biosolids segments including By Type (Class A, Class A EQ, Class B), By Form (Cakes, Liquid, Pellets), By Application (Agriculture Land Application, Non-Agriculture Land Application, Energy Recovery), By Source (Municipal Utilities, Industrial Facilities) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Biosolids Industry Overview

Regulatory Developments and Sustainability Goals Shaping the Biosolids Industry

The biosolids industry is undergoing significant transformation as municipalities, wastewater treatment authorities, environmental agencies, and agricultural stakeholders seek sustainable solutions for wastewater residual management. Biosolids are increasingly recognized as valuable resources that can support soil improvement, land restoration, and nutrient recycling initiatives. At the same time, the industry faces growing regulatory scrutiny related to environmental contaminants, land application practices, and public health considerations. As governments and utilities pursue circular economy objectives, biosolids management strategies are evolving toward higher-value reuse applications, advanced treatment technologies, and enhanced regulatory compliance frameworks.

PFAS Regulations Creating a Complex Compliance Environment

One of the most significant issues affecting the biosolids industry is the evolving regulatory landscape surrounding per- and polyfluoroalkyl substances (PFAS). As of early 2026, regulatory approaches remain fragmented across jurisdictions. While the U.S. Environmental Protection Agency continues to re-evaluate draft PFAS risk assessments related to biosolids, individual states have implemented varying restrictions and requirements. Maine has enacted a ban on the land application of biosolids, while Connecticut prohibits the use of biosolids that exceed specific PFAS concentration thresholds. These differing regulatory approaches are creating new compliance challenges for wastewater utilities, treatment operators, and biosolids management organizations while driving increased demand for PFAS monitoring and treatment technologies.

Land Reclamation and Soil Amendment Applications Expanding

Regional wastewater authorities are increasingly promoting beneficial reuse pathways for biosolids rather than relying on landfill disposal. Reports from organizations such as the Capital Regional District highlight a growing emphasis on using biosolids for land reclamation projects and non-agricultural soil amendment applications. These programs utilize Class A processing standards to ensure compliance with stringent metal concentration and fecal coliform requirements. By converting wastewater residuals into safe and beneficial products, treatment facilities are supporting environmental restoration efforts while reducing landfill dependence. The increasing adoption of Class A biosolids processing reflects a broader industry movement toward resource recovery and sustainable waste management practices.

Technology Innovation Supporting Advanced Biosolids Processing

Industry organizations continue to play an important role in advancing biosolids treatment technologies and knowledge sharing. The Water Environment Federation actively hosts specialized conferences, including the Residuals, Biosolids and Treatment Technology Conference, which brings together wastewater utilities, technology developers, and environmental professionals. These events focus on innovative solutions for transforming wastewater solids into odor-controlled, pathogen-reduced products suitable for beneficial use applications. The industry’s emphasis on advanced treatment technologies is helping improve biosolids quality, enhance public acceptance, and support the development of more sustainable wastewater resource recovery systems.

Biosolids Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Biosolids market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Veolia Environnement S.A., Suez S.A., Sabesp (Companhia de Saneamento Básico do Estado de São Paulo), Beijing Enterprises Water Group Limited, Aqualia (FCC), Sound Global Ltd., Saur Group, American Water Works Company, Inc., Thames Water Utilities Limited, Severn Trent Plc. The Biosolids market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Biosolids industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Biosolids Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Biosolids companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Biosolids markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Biosolids Market Competitive Benchmarking and Company Analysis

Leading companies in Biosolids industry include- Veolia Environnement S.A., Suez S.A., Sabesp (Companhia de Saneamento Básico do Estado de São Paulo), Beijing Enterprises Water Group Limited, Aqualia (FCC), Sound Global Ltd., Saur Group, American Water Works Company, Inc., Thames Water Utilities Limited, Severn Trent Plc. The Biosolids market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Biosolids Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Biosolids market remains one of the strongest-performing segments in the country.
The US Biosolids Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Biosolids market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Biosolids industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Biosolids markets

Canada's strong Biosolids sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Biosolids market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Biosolids Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Biosolids market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Biosolids population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Biosolids industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Biosolids market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Biosolids sales through 2034

France Biosolids companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Biosolids Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Biosolids distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Biosolids Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Biosolids market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Biosolids industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Biosolids industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Biosolids Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Biosolids market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Biosolids market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Biosolids Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Biosolids Market Segmentation

By Type
Class A
Class A EQ
Class B
By Form
Cakes
Liquid
Pellets
By Application
Agriculture Land Application
Non-Agriculture Land Application
Energy Recovery
By Source
Municipal Utilities
Industrial Facilities

Top Companies in Biosolids Industry

Veolia Environnement S.A.
Suez S.A.
Sabesp (Companhia de Saneamento Básico do Estado de São Paulo)
Beijing Enterprises Water Group Limited
Aqualia (FCC)
Sound Global Ltd.
Saur Group
American Water Works Company, Inc.
Thames Water Utilities Limited
Severn Trent Plc

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa